|
AK3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.17460485782317E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.77849956983778E-11 |
| Normal-vs-Stage2 |
1.11239906175342E-11 |
| Normal-vs-Stage3 |
2.29083418901155E-12 |
| Normal-vs-Stage4 |
1.83320025826106E-12 |
| Stage1-vs-Stage2 |
7.235400E-01 |
| Stage1-vs-Stage3 |
1.310210E-01 |
| Stage1-vs-Stage4 |
3.339100E-03 |
| Stage2-vs-Stage3 |
3.425600E-01 |
| Stage2-vs-Stage4 |
6.623800E-02 |
| Stage3-vs-Stage4 |
2.601000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.86812845379836E-12 |
| Normal-vs-AfricanAmerican |
3.60960150658229E-11 |
| Normal-vs-Asian |
5.72580000000045E-05 |
| Caucasian-vs-AfricanAmerican |
1.196590E-01 |
| Caucasian-vs-Asian |
7.465400E-01 |
| AfricanAmerican-vs-Asian |
4.360000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.44864153795288E-12 |
| Normal-vs-Female |
7.47939488121574E-11 |
| Male-vs-Female |
1.535540E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.21045404202869E-12 |
| Normal-vs-Extreme_Weight |
3.72146757854352E-12 |
| Normal-vs-Obese |
6.65556498802289E-12 |
| Normal-vs-Extreme_Obese |
9.51919999999662E-05 |
| Normal_Weight-vs-Extreme_Weight |
4.454400E-02 |
| Normal_Weight-vs-Obese |
3.669000E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.269400E-01 |
| Extreme_Weight-vs-Obese |
2.105400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.319360E-01 |
| Obese-vs-Extreme_Obese |
1.568390E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.35620403796111E-11 |
| Normal-vs-Age(41-60Yrs) |
1.91640037172647E-11 |
| Normal-vs-Age(61-80Yrs) |
7.26496640623964E-12 |
| Normal-vs-Age(81-100Yrs) |
9.08384478748303E-12 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.756400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.507200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.437200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.292400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.839800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.383600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.17852427606158E-12 |
| Normal-VS-Type2 PRCC |
3.99680288865056E-15 |
| Normal-VS-KIRP CIMP |
1.22489999998532E-06 |
| Normal-VS-Unclassified PRCC |
3.65030228266505E-12 |
| Type1 PRCC-VS-Type2 PRCC |
1.618630E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.323600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.008600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.117400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.182800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.435800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.23785442901681E-12 |
| Normal-vs-N1 |
2.19935181178244E-13 |
| Normal-vs-N2 |
1.64568358940187E-12 |
| N0-vs-N1 |
2.753000E-01 |
| N0-vs-N2 |
6.33089999999559E-05 |
| N1-vs-N2 |
1.027610E-02 |
|
|
